Alterity Therapeutics Files 6-K, Incorporates into S-8/F-3 Filings

TL;DR

ALTERITY THERAPEUTICS LTD (ATHE) filed a 6-K, incorporating it into existing S-8 and F-3 filings. Nothing new, just housekeeping.

AI Summary

Alterity Therapeutics Ltd. filed a Form 6-K on September 2, 2025, for the month of August 2025. This report is being incorporated by reference into several of the company's existing Registration Statements on Form S-8 and Form F-3. The filing includes Exhibit 99.1, an Appendix 4G.

Why It Matters

This filing indicates ongoing regulatory activity and integration of information into existing securities registration statements, which is relevant for investors tracking the company's compliance and capital-raising activities.

Risk Assessment

Risk Level: low — The filing is primarily a procedural incorporation by reference into existing registration statements, with no new material financial or operational information disclosed.

Key Players & Entities

• Alterity Therapeutics Ltd. (company) — Registrant
• 333-251073 (registration_statement) — Form S-8 File Number
• 333-248980 (registration_statement) — Form S-8 File Number
• 333-228671 (registration_statement) — Form S-8 File Number
• 333-274816 (registration_statement) — Form F-3 File Number
• 333-251647 (registration_statement) — Form F-3 File Number
• 333-231417 (registration_statement) — Form F-3 File Number
• 333-250076 (registration_statement) — Form F-3 File Number
• Appendix 4G (document) — Exhibit

FAQ

Filing Documents

• ea0255208-6k_alterity.htm (6-K) — 14KB
• ea025520801ex99-1_alterity.htm (EX-99.1) — 106KB
• 0001213900-25-082896.txt ( ) — 121KB

From the Filing

OF FOREIGN PRIVATE ISSUER SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-163 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2025 Alterity Therapeutics Limited (Name of Registrant) Level 14, 350 Collins Street, Melbourne, Victoria 3000 Australia (Address of Principal Executive Office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F This Form 6-K is being incorporated by reference into our Registration Statement on Form S-8 (Files No. 333-251073 , 333-248980 and 333-228671 ) and our Registration Statements on Form F-3 (Files No. 333-274816 , 333-251647 , 333-231417 and 333-250076 ) ALTERITY THERAPEUTICS LIMITED (a development stage enterprise) The following exhibits are submitted: 99.1 Appendix 4G 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Alterity Therapeutics Limited By: /s/ Geoffrey P. Kempler Geoffrey P. Kempler Chairman Date: August 29, 2025 2

View Full Filing

View this 6-K filing on SEC EDGAR